PSA vs SCL · rev $4.82B vs P/E 22, rev $2.18B
PSA (PSA) versus Stepan Company (SCL) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
PSA currently screens at market cap $0. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Not investment advice. Open the PSA and SCL stock pages for the full models.
Not investment advice.